标题
Regorafenib for cancer
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 6, Pages 879-889
出版商
Informa Healthcare
发表日期
2012-05-11
DOI
10.1517/13543784.2012.684752
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Explaining the Unexplainable: EGFR Antibodies in Colorectal Cancer
- (2012) Axel Grothey et al. JOURNAL OF CLINICAL ONCOLOGY
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- 7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)
- (2011) T. Eisen et al. EUROPEAN JOURNAL OF CANCER
- Protocol Information Provides Opportunity for Patient Safety and Quality Improvement
- (2011) Thomas J. George et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Properties of Current Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
- (2011) George D. Demetri SEMINARS IN ONCOLOGY
- Experience with sorafenib and adverse event management
- (2010) Joaquim Bellmunt et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Cyclophosphamide, Vincristine, and Prednisone Followed by Tositumomab and Iodine-131–Tositumomab in Patients With Untreated Low-Grade Follicular Lymphoma: Eight-Year Follow-Up of a Multicenter Phase II Study
- (2010) Brian K. Link et al. JOURNAL OF CLINICAL ONCOLOGY
- Personalized Medicine in Non–Small-Cell Lung Cancer: IsKRASa Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?
- (2010) Patrick J. Roberts et al. JOURNAL OF CLINICAL ONCOLOGY
- PharmaForum
- (2010) ONKOLOGIE
- Renal Effects of Anti-angiogenesis Therapy: Update for the Internist
- (2009) Faina Gurevich et al. AMERICAN JOURNAL OF MEDICINE
- Management of hypertension in angiogenesis inhibitor-treated patients
- (2009) H. Izzedine et al. ANNALS OF ONCOLOGY
- 7105 Phase II trial of the oral multikinase inhibitor BAY 73–4506 as 1st-line therapy in patients with metastatic or unresectable renal cell cancer (RCC)
- (2009) T. Eisen et al. EJC SUPPLEMENTS
- VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
- (2009) Hassane Izzedine et al. EUROPEAN JOURNAL OF CANCER
- Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
- (2009) Merrill S. Kies et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy
- (2009) Francesco Torino et al. Nature Reviews Clinical Oncology
- Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib
- (2009) Adam D. Lipworth et al. ONCOLOGY
- Histologic Results of Para-Aortic Lymphadenectomy in Patients Treated for Stage IB2/II Cervical Cancer With Negative [18F]Fluorodeoxyglucose Positron Emission Tomography Scans in the Para-Aortic Area
- (2008) Mathias Boughanim et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now